Case report: Varicella-zoster virus infection triggering progressive encephalomyelitis with rigidity and myoclonus

Jing Yuan1, Aihua Wang1, Yunfeng Hou2

  • 1Department of Neurology, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China.

Frontiers in Neurology
|December 16, 2022
PubMed

Insights

This case study details a patient with varicella-zoster virus infection who developed anti-glycine receptor (GlyR) antibody-positive progressive encephalomyelitis with rigidity and myoclonus (PERM). Treatment improved spasms, but the patient later passed away.

Area of Science:

  • Neurology
  • Immunology
  • Virology

Background:

  • Progressive encephalomyelitis with rigidity and myoclonus (PERM) is a rare neurological disorder.
  • PERM is often associated with anti-glycine receptor (GlyR) antibodies.
  • The etiology of PERM remains largely unknown.

Observation:

  • A patient with varicella-zoster virus (VZV) infection developed PERM.
  • Symptoms included brainstem dysfunction (hoarse voice, dysphagia), sympathetic hyperactivity, and severe spasms.
  • Anti-GlyR antibodies were detected in serum and cerebrospinal fluid.

Findings:

  • The patient was diagnosed with anti-GlyR antibody-positive PERM secondary to VZV infection.
  • Treatment with methylprednisolone and gamma globulin led to improvement in spasms.
  • Despite treatment, the patient experienced a fatal outcome after early discharge.

Implications:

  • This case highlights a potential link between VZV infection and anti-GlyR antibody-mediated PERM.
  • It underscores the importance of recognizing VZV as a potential trigger for autoimmune neurological disorders.
  • Early diagnosis and management of anti-GlyR antibody-positive PERM are crucial, even in the context of viral infections.